Vitae Surges Off Positive Results Of Psoriasis Trial

Vitae Pharmaceuticals Inc VTAE shares are trading higher by $3.19 at $7.30 in Thursday's session. The catalyst for the rally is positive news relating to the company's experimental Psoriasis drug.

After a higher open, the rally continued until it found resistance at $8.38 and reversed course. The ensuing decline took the issue down to $6.51. Since making the low, it has been finding intra-day resistance at $7.55.